Charting New Roads
Awareness changes your destiny
New Blood Test to Significantly Improve Detection of Recurring Cancer
A new blood test known as Signatera has shown incredible ability to detect cancer relapses long before traditional scans, making it a game changer for patients.
New Parp Inhibitor Lynparza May Be Important Tool for Treating Early-Stage Breast Cancer
The President of the American Society for Clinical Oncology shared that new research has found that the Lynparza parp inhibitor could have a significant impact
How New Research Into Ancestry Can Help With Alzheimer’s Disease Awareness and Management
New research finds a connection between ancestry and Alzheimer’s disease, which can help improve early detection and management.
Ezer Mizion: My Passion Project
Read about Alex Dembitzer’s connection to Ezer Mizion, an organization in Israel that has impacted the lives of thousands in need.
New Remarkable Results in PARP Inhibitors Research Tackling Advanced and Returning Ovarian Cancer
Findings from a PARP inhibitor study presented at the Society of Gynecologic Oncology’s virtual medical conference have shown promising results.
Understanding BRCA1 and BRCA2 Mutation Genes: Risk, Prevention, and Moving Forward
What are BRCA1 and BRCA2 mutated genes? Who is at risk? What does prevention/counseling look like for those with the mutation?
Neurologist Dr. Ophir Keret Partners With Ezer Mizion to Help Early Onset Dementia Patients
The Tzippora Fried Alzheimer’s Center in Israel has continued to operate in full swing over the past year, despite the challenges of the coronavirus.
The Tzippora Fried Alzheimer’s Center in Israel
The Tzippora Fried Alzheimer’s Center in Israel has continued to operate in full swing over the past year, despite the challenges of the coronavirus.
How CRISPR Technology Can Be Used to Treat Cancer
Researchers at Tel Aviv University have successfully treated cancer in mice using gene-editing CRISPR technology.
New Research Can Help Identify Certain Lung Cancer Treatment
Researchers from the Moffitt Cancer Center have developed a deep learning model that can identify the course of treatment for certain types of lung cancer.